Document Detail

Malignant inguinal monophasic synovial sarcoma: report of a case and review of the literature.
Jump to Full Text
MedLine Citation:
PMID:  21092139     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: A synovial sarcoma (SS) is an aggressive soft tissue tumor that classically occurs in the extremities near, but rarely within large joints, in young adults. Variable symptoms and clinical manifestations may be encountered and a definite diagnosis should depend on pathological results. This poses certain difficulties in arriving at a prompt diagnosis and appropriate treatment.
CASE PRESENTATION: We report the case of a 68-year-old woman patient who presented an inguinal mass with swelling and pain in the right lower limb. She underwent surgery, and later received systematic intravenous chemotherapy. The pathological studies, especially the specific chromosomal translocation of a t(X;18) (p11.2;q11.2), confirmed the diagnosis as a synovial sarcoma. To the best of our knowledge, this is the first report of a monophasic synovial sarcoma in the inguinal region.
CONCLUSION: Besides making the readership aware of the rarity of location and age of this present case, this report distinctly highlights the great value of a molecular analysis of an SYT associated genetic alteration in the diagnosis of synovial sarcoma occurring at rare sites especially when immunochemical results are equivocal.
Ji Xu; Jia Wang; Long Cui; Xiangru Wu
Related Documents :
15682739 - Myelopathy caused by a histiocytic sarcoma in a cat.
18798779 - Mr imaging of primary spinal germinoma: a case report and review of the literature.
14985009 - Spinal subdural hematoma following craniotomy: case report.
19349809 - Primary intramedullary melanocytoma of the spinal cord: case report.
19644329 - Instrumentation and fusion for congenital spine deformities.
3882299 - Chemonucleolysis failures treated by plif.
18346919 - Speciation in fungi.
17172069 - Steroid-induced psychosis in an adolescent: treatment and prophylaxis with risperidone.
24250089 - Myoepithelioma of minor salivary glands - a diagnostic challenge: report of three cases...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2010-11-21
Journal Detail:
Title:  World journal of surgical oncology     Volume:  8     ISSN:  1477-7819     ISO Abbreviation:  World J Surg Oncol     Publication Date:  2010  
Date Detail:
Created Date:  2010-12-02     Completed Date:  2011-02-01     Revised Date:  2013-07-03    
Medline Journal Info:
Nlm Unique ID:  101170544     Medline TA:  World J Surg Oncol     Country:  England    
Other Details:
Languages:  eng     Pagination:  102     Citation Subset:  IM    
Department of Surgery, Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abdominal Neoplasms / diagnosis*,  drug therapy,  surgery
Antineoplastic Agents / therapeutic use
Diagnosis, Differential
Follow-Up Studies
Inguinal Canal*
Sarcoma, Synovial / diagnosis*,  drug therapy,  surgery
Tomography, X-Ray Computed
Ultrasonography, Doppler
Reg. No./Substance:
0/Antineoplastic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): World J Surg Oncol
ISSN: 1477-7819
Publisher: BioMed Central
Article Information
Download PDF
Copyright ©2010 Xu et al; licensee BioMed Central Ltd.
Received Day: 3 Month: 1 Year: 2010
Accepted Day: 21 Month: 11 Year: 2010
collection publication date: Year: 2010
Electronic publication date: Day: 21 Month: 11 Year: 2010
Volume: 8First Page: 102 Last Page: 102
Publisher Id: 1477-7819-8-102
PubMed Id: 21092139
DOI: 10.1186/1477-7819-8-102

Malignant inguinal monophasic synovial sarcoma: report of a case and review of the literature
Ji Xu1 Email:
Jia Wang2 Email:
Long Cui1 Email:
Xiangru Wu2 Email:
1Department of Surgery, Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China 200092
2Department of Pathology, Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China 200092


A synovial sarcoma (SS) is an aggressive soft tissue tumor, which mainly occurs in the para-articular region of extremities with a predilection of lower limb. It usually develops in adolescents and young adults between the age of 15 and 40 years [1-3]. The detection of a reciprocal translocation between chromosomes X and 18 t(X:18) has led to the identification of an SS18 gene(also known as SYT) rearrangement being involved in the formation of a SYT-SSX fusion protein in synovial sarcomas[4-6]. With the advent of immunohistochemistry and molecular techniques, cases of synovial sarcomas have been reported in unusual location including the head and neck[7], mediastinum[8], lung[9], abdominal wall[10], intraabdominal[11], kidney[12] and retroperitoneum[13]. Isolated rare cases were mentioned in the vulva [14], skin [15], blood vessels [16] and nerves [17].

Inguinal synovial sarcomas are rare findings with only one case report in the English literature [18]. Here we report a case of an inguinal synovial sarcoma presented with pain and swelling in the right lower limb.

Case report

A 68-year-old woman was admitted with a complaint of swelling and pain in her right lower limb. She had felt a progressive swelling and pain for more than two months without any obvious cause. Subsequently, she was referred to a vascular surgery clinic where a mass was found in the right inguinal area by physical examination. The mass was like a goose-egg in shape, hard, fixed and couldn't disappear under pressure. A Doppler ultrasonic vessel examination suggested that there were small blood clots and reduced blood flow in the veins of the right lower limb. Correspondingly, CT and CT angiography (CTA) scans were conducted which displayed a mass in her right inguinal area with involvement of the femoral vein (Figure 1, 2). The patient did not have any family history. She had never smoked and had a normal chest X- ray exam.

A surgical excision was performed which revealed a tumor located in the right inguinal region with adhesion to the right femoral vein and artery. The tumor was completely resected with negative margin. Grossly, the specimen was 8 cm × 6 cm × 4.5 cm in size and the cut surface was firm and white-to-tan. Microscopic appearances were monomorphic, highly cellular composed of plump, spindled cells growing in short fascicles. The tumor cells had ovoid nuclei and minimal cytoplasm with frequent mitotic activity and atypical nuclei (Figure 3). Immunohistochemically, the tumor cells were positive for the epithelial membrane antigen(EMA), calretinin, cytokeratin(CK), vimentin (VIM), but negative for smooth muscle actin(SMA), muscle specific actin(MSA), CD117 and S100. The molecular analysis of the paraffin-embedded neoplasm sample by fluorescence in situ hybridization (FISH) revealed a SYT-SSX fusion transcript (Figure 4). Based on these findings, a primary malignant synovial sarcoma was diagnosed while the other most likely diagnosis of a sarcomatoid mesothelioma was excluded.

For personal reasons, the patient refused to receive any chemotherapy after the operation. Unfortunately, lung and spleen metastasis were found 15 months after operation in a routine postoperative follow-up. The patient was referred to the oncology department where she received systemic intravenous chemotherapy (ifosfamide, doxorubicin and cisplatin). However, the patient responded poorly to the treatment and finally died 9 months later due to an initially poor and subsequently rapidly worsening condition.


Synovial sarcomas are uncommon soft tissue tumors accounting for 5-10% of the soft tissue sarcomas. They usually develop in children and young adults and approximately 95% of SSs occur in the extremities. They can metastasize distantly, especially to the lung and lymph node [1].

Two major histologic subtypes exist: monophasic and biphasic synovial sarcomas. The classical SS has a biphasic appearance with a mixture of epithelial and spindle cells in varying proportions. The monophasic SS consisting solely of sarcomatous components is often diagnostically challenging. Synovial sarcomas typically occur in patients between the age of 15 and 40 years, rarely in the elderly. Patients commonly present with a palpable mass or swelling, associated with pain in almost half of the patients. The most common sites include the lower extremities (60%), with a special predilection for the knee area; the upper extremities (23%); the head and neck region (9%), particularly in the retropharyngeal and parapharyngeal areas; and the trunk (8.1%), most commonly involving the abdominal wall or retroperitoneum[1]. SSs occuring in the inguinal region are exceedingly rare. In a retrospective review of 20 patients, Huub[19] et al mentioned one SS case in the groin region but with no detailed documentation. The only reported case in the English literature is that of a 19-year-old Japanese female patient with the classic biphasic form of SS[18]. No immunohistochemical or further pathological analysis findings were mentioned in that brief report.

In our case, heavily stained nucleus, mitotic activity and atypical spindle-shaped cells with an increase in nucleus to cytoplasm ratio were observed under the light microscope. A panel of immunohistochemical staining was done for differential diagnosis. The spindle cells were positive for epithelial membrane antigen (EMA), calretinin, cytokeratin (CK), vimentin (VIM) and proliferating cell nuclear antigen (PCNA), but negative for smooth muscle actin(SMA), muscle specific actin(MSA), CD117 and S100. These findings helped to exclude the presence of a leiomyosarcoma, malignant peripheral nerve sheath tumor(MPNST), gastrointestinal stromal tumor(GIST). Despite of a panel of immunohistochemical staining results, however, to distinguish between sarcomatoid mesothelioma and synovial sarcoma was extremely difficult because both types of tumors share the same immunostaining results. They show an overlap in their respective immumostaining spectrum of EMA, calretinin, vimentin and S-100. To date, there exist no ideal immunohistochemical markers to reliably diagnose the SS and make an unequivocal distinction. The gold standard applied in order to confirm the diagnosis of SS is to detect the specific t(X;18)(p11.2;q11.2) translocation[4,20] at molecular level. The t(X;18)(p11.2;q11.2) translocation is a cytogenetic hallmark of the SS and is present in more than 90% of the cases[21]. The SS18-SSX fusions do not seem to occur in other types of sarcomas. To determine whether the SYT-SSX fusion transcript associated with t(X;18) translocation is present, a dual-color break-apart fluorescence in situ hybridization (FISH) assay for SYT gene disruption was performed in paraffin-embedded tumor material, which showed a positive result. As the t(X;18) translocation is unique to the SS, its identification provided the definite diagnosis for this case. We consider this FISH assay described by Surace et al [22], a preferred clinical method in the diagnosis, especially when sufficient quality of RNA for PCR could not be extracted. Apart from its diagnostic value, this translocation fusion type was found to be the single most significant prognostic factor by multivariate analysis in SS patients [23]. However, a European retrospective analysis found that the most important factor in determining the prognosis of these patients is histological grade, and not SYT-SSX fusion type [24].

Surgery is the mainstay treatment. Chemotherapy and radiation therapy should be considered as additional treatment options or may be utilized in cases of relapse. Prognosis is poor with local recurrence and metastases in almost 50% of the patient [1]. Metastases occur mainly to lungs as was the case for this patient. Since Ifosfamide based chemotherapy has been shown to produce notable responses in the treatment of metastatic SS [25], however, its effect on this patient was not satisfactory. Finally, despite the surgery and chemotherapy she had received, our patient has only survived for less than two and a half years after her initial clinical presentation.

Currently, with known genetic alterations in SSs, new therapies targeting DNA or protein are under investigation. Vaccine of SYT-SSX junction peptide was tested in a pilot study [26]. Recent studies shows retinoic acid and its derivatives could induce the differentiation of SS cell lines and inhibit cell growth both in vitro and in vivo [27]. However, the therapeutic efficacy is still under evaluation.

In conclusion, this is the first report of a monophasic synovial sarcoma in the inguinal region. We report this unusual case because of the tumor location and patient's old age. The case illustrates possible differential diagnoses before the treatment. It also highlights the value of molecular analysis in ascertaining the diagnosis of a synovial sarcoma at a rare site, especially when immunohistochemical results are equivocal.


Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

JX performed surgery on the patient and participated in designing the report and also was involved in data acquisition and interpretation, writing initial drafts and subsequent revisions and undertook review of literature on topic. JW made a substantial contribution regarding conception of report, made many suggestions regarding pathological issues contained in the report and undertook review of pertinent literature on topic. XW made a substantial contribution regarding pathological molecular analysis. LC made a substantially contributed to the concept of this case report, supervised the work and drafts of the case report prepared by the first and second authors. All authors read and approved the final version of the article to be submitted for publication.

Weiss SW,Goldblum JR,Weiss SW, Goldblum JRSynovial sarcomaEnzinger and Weiss's soft tissue tumoursYear: 2001Mosby: London309346
Cagle LA,Mirra JM,Storm FK,Roe DJ,Eilber FR,Histologic features relating to prognosis in synovial sarcomaCancerYear: 1987591810181410.1002/1097-0142(19870515)59:10<1810::AID-CNCR2820591021>3.0.CO;2-R3828949
Tsuji S,Hisaoka M,Morimitsu Y,Hashimoto H,Shimajiri S,Komiya S,Ushijima M,Nakamura T,Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription- polymerase chain reaction using archival paraffin-embedded tissuesAm J PatholYear: 19981531807129846971
Clark J,Rocques PJ,Crew AJ,Gill S,Shipley J,Chan AM,Gusterson BA,Cooper CS,Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomaNat GenetYear: 1994750250810.1038/ng0894-5027951320
Crew AJ,Clark J,Fisher C,Gills S,Grimer R,Chand A,Shipley J,Gusterson BA,Cooper CS,Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcomaEMBO JYear: 199514233323407539744
Pfeifer JD,Hill DA,O'Sullivan MJ,Dehner LP,Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics?HistopathologyYear: 20003748550010.1046/j.1365-2559.2000.01107.x11122430
Tilakaratne WM,Synovial sarcoma of the mandibleJ Oral Pathol MedYear: 200635616310.1111/j.1600-0714.2005.00375.x16393257
Witkin GB,Miettinen M,Rosai J,A biphasic tumor of the mediastinum with features of synovial sarcoma. A report of 4 casesAm J Surg PatholYear: 19891349049910.1097/00000478-198906000-000052471414
Zeren H,Moran CA,Suster S,Fishback NF,Koss MN,Primary pulmonary sarcomas with features of monophasic synovial sarcoma: a clinicopathological, immunohistochemical, and ultrastructure study of 25 casesHum PatholYear: 19952647448010.1016/0046-8177(95)90242-27750931
Fetsch JF,Meis JM,Synovial sarcoma of the abdominal wallCancerYear: 19937246947710.1002/1097-0142(19930715)72:2<469::AID-CNCR2820720224>3.0.CO;2-Q8391380
Fisher C,Folpe AL,Hashimoto H,Weiss SW,Intra-abdominal synovial sarcoma: a clinicopathological studyHistopathologyYear: 20044524525310.1111/j.1365-2559.2004.01950.x15330802
Jun SY,Choi J,Kang GH,Park SH,Ayala AG,Ro JY,Synovial sarcoma of the kidney with rhabdoid features: report of three casesAm J Surg PatholYear: 20042863463715105652
Adam YG,Oland J,Halevy A,Reif R,Primary retroperitoneal soft-tissue sarcomasJ Surg OncolYear: 19842581110.1002/jso.29302501036319825
White BE,Kaplan A,Lopez-Terrada DH,Ro JY,Benjamin RS,Ayala AG,Monophasic Synovial Sarcoma Arising in the Vulva. A Case Report and Review of the LiteratureArch Pathol Lab MedYear: 200813269870218384223
Fleider DB,Moran CA,Primary cutaneous synovial sarcoma: a case reportAm J DermatopatholYear: 19982050951210.1097/00000372-199810000-000179790117
Miettinen M,Santavirta S,Slatis P,Intravascular synovial sarcomaHum PatholYear: 1987181075107710.1016/S0046-8177(87)80227-72820861
O'Connell JX,Browne WL,Gropper PT,Berean KW,Intraneural biphasic synovial sarcoma: an alternative "glandular" tumor of peripheral nerveMod PatholYear: 199697387418832556
Naito N,Ozaki T,Kunisada T,Kawai A,Dan'ura T,Morimoto Y,Inoue H,Synovial sarcoma with a large hematoma in the inguinal regionArch Orthop Trauma SurgYear: 200012053353410.1007/s00402990010911011677
van der Heide Huub JL,Veth Rene PH,Pruszczynski Maciej,Wobbes Theo,van Hoesel Quirinus GCM,Lemmens Josef AM,Synovial sarcoma: oncological and functional resultsEur J of Surg OncolYear: 19982411411910.1016/S0748-7983(98)91433-0
Coindre JM,Pelmus M,Hostein I,Lussan C,Bui BN,Guillou L,Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 casesCancerYear: 2003982700270710.1002/cncr.1184014669292
Begueret H,Galateau-Salle F,Guillou L,Chetaille B,Brambilla E,Vignaud JM,Terrier P,Groussard O,Coindre JM,Primary intrathoracic synovial sarcoma: a clinicopathologic study of 40 t(X:18)- positive cases from French sarcoma group and the mesopath groupAm J Surg PatholYear: 20052933934610.1097/01.pas.0000147401.95391.9a15725802
Surace C,Panagopoulos I,Palsson E,Rocchi M,Mandahl N,Mertens F,A novel FISH assay for SS18-SSX fusion type in synovial sarcomaLab InvestYear: 200484911859210.1038/labinvest.370014215208645
Ladanyi M,Antonescu CR,Leung DH,Woodruff JM,Kawai A,Healey JH,Brennan MF,Bridge JA,Neff JR,Barr FG,Goldsmith JD,Brooks JS,Goldblum JR,Ali SZ,Shipley J,Cooper CS,Fisher C,Skytting B,Larsson O,Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patientsCancer ResYear: 20026213514011782370
Guillou L,Benhattar J,Bonichon F,Gallagher G,Terrier P,Stauffer E,Somerhausen Nde S,Michels JJ,Jundt G,Vince DR,Taylor S,Genevay M,Collin F,Trassard M,Coindre JM,Histologic grade, but not SYTSSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysisJ Clin OncolYear: 2004224040405010.1200/JCO.2004.11.09315364967
Eilber FC,Dry SM,Diagnosis and Management of Synovial SarcomaJ Surg OncolYear: 20089731432010.1002/jso.2097418286474
Kawaguchi S,Wada T,Ida K,Sato Y,Nagoya S,Tsukahara T,Kimura S,Sahara H,Ikeda H,Shimozawa K,Asanuma H,Torigoe T,Hiraga H,Ishii T,Tatezaki SI,Sato N,Yamashita T,Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcomaJ Transl MedYear: 200531910.1186/1479-5876-3-115647119
Ishibe T,Nakayama T,Aoyama T,Nakamura T,Toguchida J,Neuronal differentiation of synovial sarcoma and its therapeutic applicationClin Orthop Relat ResYear: 20084662147215510.1007/s11999-008-0343-z18563503


[Figure ID: F1]
Figure 1 

Pre-operative CT scan showing a pelvis mass (M) adjacent to the femoral artery (arrow) and femoral vein (arrowhead).

[Figure ID: F2]
Figure 2 

Pre-operative CTA showing a pelvis mass (M) compressing the right femoral artery (arrow) and especially the femoral vein (arrowhead).

[Figure ID: F3]
Figure 3 

Histological section (haematoxylin and eosin, original magnification: ×200). The tumor consisted of atypical spindle-shaped cells, which arranged in fascicles.

[Figure ID: F4]
Figure 4 

FISH result shows a break-apart red and green signal per nucleus in SS tumor cells (arrows), indicating the presence of a t(X;18) translocation.

Article Categories:
  • Case Report

Previous Document:  Expression of 3-hydroxy-3-methylglutaryl-CoA reductase, p-hydroxybenzoate-m-geranyltransferase and g...
Next Document:  GSK3 regulates the expressions of human and mouse c-Myb via different mechanisms.